Target intelligence / Profile preview

Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (STT3A)

Target
STT3A
Molecular classification
Enzyme, Transferase, Glycosyltransferase, Oligosaccharyltransferase (OST) complex subunit
01

Overview

Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A is the primary catalytic subunit of the oligosaccharyltransferase (OST) complex, which resides in the endoplasmic reticulum (ER) membrane (UniProt P46977). It is specifically responsible for co-translational N-glycosylation, a process where a pre-assembled oligosaccharide is transferred to the asparagine residue of a nascent polypeptide as it is being synthesized (PubMed: 25417110). This modification is essential for the correct folding, stability, and biological activity of a vast majority of secretory and membrane proteins. Mutations in the STT3A gene lead to congenital disorders of glycosylation (CDG-Iv), which manifest as severe developmental delays and neurological impairments (PubMed: 24532530). In therapeutic research, STT3A is targeted by small molecules like NGI-1 to disrupt the glycosylation of oncogenic receptors or viral glycoproteins, thereby inhibiting cancer progression or viral replication (PubMed: 27524445). However, because N-glycosylation is a fundamental cellular process, pharmacological targeting of STT3A carries a high risk of off-target toxicity and ER stress-induced cell death.

Other names
STT3-AOligosaccharyltransferase subunit STT3AIntegral membrane protein 1ITM1BWSSTT3A-OST
02

Mechanism of action

Inhibition of the catalytic subunit of the oligosaccharyltransferase complex to prevent the transfer of glycan chains to nascent polypeptides.

03

Biological functions

Protein N-glycosylationCo-translational protein processingProtein foldingEndoplasmic reticulum homeostasis
04

Disease associations

Congenital disorder of glycosylation type Iv (STT3A-CDG)CancerViral infection
05

Safety considerations

Systemic toxicity due to broad inhibition of N-glycosylationEndoplasmic reticulum stressPotential developmental toxicityImpaired protein folding and trafficking
06

Interacting drugs

NGI-1
07

Biomarkers

Serum transferrin isoelectric focusingN-glycan profilingHypoglycosylated glycoproteins

Beyond the preview

Go deeper on Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (STT3A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit STT3A (STT3A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call